Mr. Speaker, of course I expect Health Canada to take all drug safety issues very seriously and we will not tolerate any drug safety risks. The member knows that when this information became available to Health Canada and it was able to see the technical reports and do its own analysis, we immediately moved to ban several companies that are situated in India. We will continue to do exactly that when we get any information like this.
In the House of Commons on November 6th, 2014. See this statement in context.